Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5072412016 | Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5072413014 | Product containing precisely levocetirizine dihydrochloride 5 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has precise active ingredient | Montelukast sodium | true | Inferred relationship | Some | 1 | |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has basis of strength substance (attribute) | Montelukast (substance) | true | Inferred relationship | Some | 1 | |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has precise active ingredient | Levocetirizine dihydrochloride (substance) | true | Inferred relationship | Some | 2 | |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has basis of strength substance (attribute) | Levocetirizine dihydrochloride (substance) | true | Inferred relationship | Some | 2 | |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Is a | Product containing only levocetirizine and montelukast in oral dose form (medicinal product form) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets